How can clinicians navigate emotionally complex patient interactions while maintaining empathy and trust? In this article, Mio Nakamura discusses communication approaches that may help strengthen patient relationships in dermatology settings.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
Palmoplantar pustulosis (PPP) is a challenging inflammatory skin disease often misclassified as psoriasis. Dr. José-Manuel Carrascosa Carrillo shares clinical perspectives on PPP pathogenesis, diagnosis, and treatment, including biologics and JAK inhibitors.
The International Psoriasis Council (IPC) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) have launched a global consensus initiative to define difficult-to-treat and treatment-refractory psoriasis, with the goal of improving clinical care, research consistency, and treatment decision-making worldwide.
Meet the 2026 IPC International Fellows, eight internationally selected clinicians and researchers advancing evidence-based psoriasis care and global collaboration through the International Psoriasis Council.
This commentary from IPC Board Member Lluís Puig examines inference-based guidance for managing immune checkpoint inhibitor-induced psoriasis and discusses how biologics and targeted systemic therapies can be used safely alongside cancer immunotherapy.
Meet the newest member of the IPC Board of Directors, Curdin Conrad, MD. Learn how his expertise will help support IPC’s mission to improve psoriasis care worldwide.
This expert overview by IPC Junior Councilor María Julia Cura examines palmoplantar pustulosis as a distinct inflammatory disease with evolving therapeutic implications.
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.
